At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 55 enrolled
Drug / intervention
Ketaminedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Low Dose Ketamine Infusion for Analgesia in the Emergency Department (ED) to Reduce Side Effects: A Double Blind, Double Dummy Randomized Controlled Trial
In Brief
A Phase 4 clinical trial evaluating Ketamine for Pain, Acute and Dissociation. Completed, enrolled 55 participants across 1 site.
Detailed Summary
This will be an intent to treat prospective, double blind, double-dummy, randomized trial. Our primary objective is the reduction of side effects of sub dissociative dose ketamine given by slow intravenous (IV) infusion over 30 minutes vs. 15 minutes in the treatment of acute, severe pain in Emergency Department (ED) patients. The secondary objective will be to maintain adequate pain control (as defined by a Visual Analog Scale (VAS) score of ≤ 5cm) at 30 minutes for both groups.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Acute, Dissociation
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2023202420252026
First PostedAug 2022
Enrollment StartDec 2022
Primary CompletionApr 2025
TodayJul 2026
First PostedAug 29, 2022
Enrollment StartDec 7, 2022
Primary CompletionApr 2, 2025
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 3.8 years ago
Interventions
Ketaminedrug
Administration of Ketamine